FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
DRI TM Tricyclics Serum Tox Assay
K Number: K213875
·
Decision Dec 21, 2022
Classifications
1
FEI Numbers
5
Registration Numbers
5
Same Product Code
5
Applicant Total
21
Review Days
373
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- DRI TM Tricyclics Serum Tox Assay
- K Number
- K213875
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.3910
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Microgenics Corporation
- Date Received
- December 13, 2021
- Decision Date
- December 21, 2022
- Product Code
- LFH
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LFH | U.V. Spectrometry, Tricyclic Antidepressant Drugs | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (LFH), ordered by most recent decision date.
Alinity c Tricyclic Antidepressants Reagent Kit
FDA 510(k)
FDA Class 2
·Clinical Toxicology
MODIFICATION OF TRICYCLIC SERUM TOX EIA ASSAY
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ACCUSIGN TCA, BIOSIGN TCA, STAUS DS TCA
FDA 510(k)
FDA Class 2
·Clinical Toxicology
TRICYCLICS SERUM TOX ASSAY
FDA 510(k)
FDA Class 2
·Clinical Toxicology
AXSYM TRICYCLIC ANTIDEPRESSANTS
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Microgenics Corporation
| K Number | Device Name | ||
|---|---|---|---|
| K243498 | Alinity c Benzodiazepines Reagent Kit | Dec 11, 2024 | Substantially Equivalent |
| K240670 | DRI Ecstasy Plus Assay | Oct 30, 2024 | Substantially Equivalent |
| K231020 | Alinity c Tricyclic Antidepressants Reagent Kit | Nov 17, 2023 | Substantially Equivalent |
| K231007 | CEDIA Heroin Metabolite (6-AM) Assay | Sep 27, 2023 | Substantially Equivalent |
| K211973 | DRI Cocaine Metabolite Assay | Sep 24, 2021 | Substantially Equivalent |
| K192943 | CEDIA Heroin Metabolite (6-AM) assay | Dec 16, 2019 | Substantially Equivalent |
| K190968 | CEDIA Benzodiazepine Assay | Dec 9, 2019 | Substantially Equivalent |
| DEN180030 | QMS Plazomicin Immunoassay | Nov 19, 2018 | Unknown |
| K181499 | DRI Cocaine Metabolite Assay | Jul 6, 2018 | Substantially Equivalent |
| K173963 | DRI Benzodiazepine Assay | Feb 21, 2018 | Substantially Equivalent |